Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GVH - Graft Versus Host Reaction”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Not applicableUnknownNCT05000112
What this trial is testing

Vaginal Microbiome-host Interaction in Mesh Exposure After TVM Surgery

Who this might be right for
Vaginal MicrobiomeGraft Versus Host Reaction
Peking Union Medical College Hospital 50
Not applicableAvailableNCT06393660
What this trial is testing

Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)

Who this might be right for
Transplant-Related DisorderGVH - Graft Versus Host Reaction
Victor Aquino
Testing effectiveness (Phase 2)UnknownNCT04969172
What this trial is testing

A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection

Who this might be right for
COVID-19 Disease
Eli Sprecher, MD 155
Testing effectiveness (Phase 2)Active Not RecruitingNCT04692181
What this trial is testing

SYN-004 Safety and Tolerability in Allo-HCT Subjects

Who this might be right for
Acute Graft-Versus-Host Reaction Following Bone Marrow TransplantPrevention of CDI in Adult Patients Being Treated With IV Beta-lactam Antibiotics
Theriva Biologics, Inc. 36
Large-scale testing (Phase 3)UnknownNCT03371667
What this trial is testing

To Compare the Efficacy of the Addition of Methotrexate (MTX) to Current Standard Acute Graft-versus-host Disease (GVHD) First-line Treatment With Corticosteroids

Who this might be right for
Allogeneic DiseaseGVH - Graft Versus Host ReactionGVHD, Acute+1 more
Assistance Publique - Hôpitaux de Paris 102
Not applicableStudy completedNCT04707417
What this trial is testing

Home Care in Allogeneic Haematopoietic Stem Cell Transplantation

Who this might be right for
Stem Cell Transplant ComplicationsQuality of LifeGVH - Graft Versus Host Reaction
Oslo University Hospital 16
Large-scale testing (Phase 3)UnknownNCT05158608
What this trial is testing

Comparison of PT-Cy at a Dose of 25 mg/kg/Day and PT-Cy at a Dose of 50 mg/kg/Day in GVHD Prophylaxis

Who this might be right for
Graft Versus Host DiseaseHematologic MalignancyCyclophosphamide Adverse Reaction
National Research Center for Hematology, Russia 100
Not applicableNo Longer AvailableNCT03172455
What this trial is testing

Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Acute-graft-versus-host DiseaseSteroid Refractory Acute Graft Versus Host DiseaseGraft-versus-host-disease+5 more
Impatients N.V. trading as myTomorrows
Testing effectiveness (Phase 2)Study completedNCT02133924
What this trial is testing

Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease

Who this might be right for
Acute Graft Versus Host Disease
John Levine 76